"Vaajanen, Anu" - Selaus tekijän mukaan TUNICRIS-julkaisut
Viitteet 1-6 / 6
-
Changes in incidence and severity of visual impairment due to glaucoma during 40 years : a register-based study in Finland
(2022)
articlePurpose: To report the incidence and severity of reported visual impairment (VI) due to glaucoma and the changes in them during the past 40 years in Finland. Methods: A register-based study, in which the data were collected ... -
The Finnish current care guideline for open-angle glaucoma
(2024)
articleThis article is an English translation of the 4th Finnish Current Care Guideline for diagnostics, treatment and follow-up of primary open-angle glaucoma, normal-tension glaucoma and pseudoexfoliative glaucoma. This guideline ... -
Glaucoma progression in patients receiving intravitreal anti-VEGF treatment for neovascular age-related macular degeneration
(2023)
articlePurpose: The purpose of this study was to investigate how often glaucoma and neovascular age-related macular degeneration (nAMD) occur in the same patient and to evaluate whether glaucoma progression is faster in eyes ... -
Immediate sequential bilateral cataract surgery : A 13-year real-life report of 56 700 cataract operations
(01.12.2023)
articleBackground/aims: To assess the frequency of immediate sequential bilateral cataract surgery (ISBCS) and endophthalmitis during 13-year period in Tays Eye Centre, Tampere University Hospital, Tampere, Finland. Methods: All ... -
A prototype protocol for evaluating the real-world data set using a structured electronic health record in glaucoma
(03 / 2024)
articlePurpose: As the first step in monitoring and evaluating day-to-day glaucoma care, this study reports all real-world data recorded during the first full year after the implementation of a prototype for glaucoma-specific ... -
Ten-year real-world outcomes of antivascular endothelial growth factor therapy in neovascular age-related macular degeneration using pro re nata regimen
(2023)
articleBackground/aims To analyse long-term outcomes of antivascular endothelial growth factor (anti-VEGF) therapy for the treatment of neovascular age-related macular degeneration (nAMD) using pro re nata (PRN) regimen in a ...
